Health Biotech and Biopharma Executive Eliana Clark Joins Culture Biosciences’ Advisory Board James Pereira Jul 19, 2023 SAN FRANCISCO, July 19, 2023 (GLOBE NEWSWIRE) -- Culture Biosciences is excited to welcome Eliana Clark, PhD,… Read More...
Health Minister Dr Tanaji Sawant stays action by NMMC on hospital – ET HealthWorld James Pereira Mar 11, 2023 Mumbai: More than a fortnight after the Navi Mumbai Municipal Corporation (NMMC) revoked the registration of Neurogen… Read More...
Health GAIA BioMedicine and TreeFrog Therapeutics Announce Collaboration for the Expansion of Allogeneic… James Pereira Feb 15, 2023 <!-- Name:DistributionId Value:1000782840 --> <!--… Read More...
Health Neurona Therapeutics Announces FDA Clearance of Expanded Inclusion Criteria for Phase I/II Clinical… James Pereira Feb 15, 2023 <!-- Name:DistributionId Value:8748523 --> <!--… Read More...
Health The cell and gene therapy CROs market is anticipated to grow at an annualized rate of 18% by 2035,… James Pereira Feb 15, 2023 <!-- Name:DistributionId Value:8745388 --> <!--… Read More...
Health Celyad Oncology provides an update on its strategic business model, continuing to focus on… James Pereira Dec 21, 2022 MONT-SAINT-GUIBERT, Belgium, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext & Nasdaq: CYAD) (the… Read More...
Health invIOs to present at upcoming industry and investor conferences James Pereira Oct 11, 2022 VIENNA, Austria, Oct. 11, 2022 (GLOBE NEWSWIRE) -- invIOs GmbH (“invIOs”), a privately held biotechnology company… Read More...
Health Lyell Immunopharma Announces FDA Clearance of its IND for LYL845, a TIL Product Candidate Enhanced… James Pereira Oct 7, 2022 Autologous TIL therapy enhanced with Lyell’s Epi-R™ reprogramming technology designed to create polyclonal T cell… Read More...
Health Biopreservation Market worth USD 9.5 Billion by 2030, says Global Market Insights Inc. James Pereira Sep 26, 2022 Selbyville, Delaware, Sept. 26, 2022 (GLOBE NEWSWIRE) -- The biopreservation market value is anticipated to cross… Read More...
Health Lyell Immunopharma Presents First in Human Trial Design of LYL797 at ESMO 2022 James Pereira Sep 12, 2022 SOUTH SAN FRANCISCO, Calif., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a… Read More...